STOK
Stoke Therapeutics Inc
24.00$
-1.4%
vs. previous close
Closing price · As of: Oct 8, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q1 18 | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | – | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 20.8% | 25.8% | 31.8% | 35.2% | 22.3% | – | 36.3% | 43.4% | 26.4% | 23.0% | 22.7% | 4.9% | 0.7% | 7.7% | 9.3% | 75.2% | 16.8% | 12.2% | 15.3% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 79.2% | 74.2% | 68.2% | 64.8% | 77.7% | – | 63.7% | 56.6% | 73.6% | 77.0% | 100.0% | 100.0% | 100.0% | 100.0% | 90.7% | 24.8% | 83.2% | 87.8% | 84.7% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 602.1% | 558.8% | 678.9% | 625.6% | 369.4% | – | 593.5% | 755.0% | 517.2% | 426.2% | 453.7% | 103.6% | 20.6% | 187.1% | 350.4% | 2,945.1% | 636.9% | 525.9% | 606.3% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 316.2% | 312.9% | 342.3% | 287.0% | 198.2% | – | 310.5% | 378.7% | 242.4% | 269.9% | 259.3% | 56.8% | 9.2% | 110.5% | 150.7% | 1,508.3% | 320.7% | 270.8% | 298.7% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 905.7% | 855.3% | 1,002.7% | 896.1% | 557.0% | – | 887.0% | 1,112.5% | 746.6% | 684.4% | 713.1% | 160.4% | 29.8% | 297.6% | 496.0% | 4,407.0% | 940.8% | 789.4% | 894.4% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -826.5% | -781.1% | -934.5% | -831.3% | -479.2% | – | -823.3% | -1,055.9% | -673.0% | -607.4% | -613.1% | -60.4% | 70.2% | -197.6% | -405.3% | -4,382.2% | -857.6% | -701.7% | -809.7% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 3.5% | 16.8% | 34.3% | 45.2% | 40.8% | – | 80.1% | 92.3% | 57.5% | 76.5% | 72.4% | – | 0.0% | 0.0% | 0.0% | 0.2% | 0.4% | 0.2% | 0.2% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -821.6% | -763.0% | -898.8% | -784.8% | -437.6% | – | -741.9% | -962.1% | -625.6% | -531.9% | -540.0% | -46.4% | 72.0% | -170.0% | -372.7% | -4,132.2% | -802.7% | -660.8% | -758.2% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -8.3% | -44.3% | -69.9% | -110.4% | -82.5% | – | -99.4% | 382.4% | 25.4% | – | -22.7% | – | 0.8% | – | -12.0% | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -821.6% | -763.0% | -898.8% | -784.8% | -437.6% | – | -741.9% | -962.1% | -625.6% | -531.9% | -540.0% | -46.4% | 71.2% | -170.0% | -360.7% | -4,132.2% | -802.7% | -660.8% | -753.6% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -800.8% | -737.1% | -867.0% | -749.6% | -415.3% | – | -705.6% | -939.8% | -612.2% | -520.5% | -529.0% | -44.0% | 72.3% | -166.7% | -363.4% | -4,103.1% | -741.2% | -696.7% | -751.4% |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 8, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.